InsidersTradesSigma
Follow the GSS share price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Health Care sector, GSS has recorded 5 reports. Market capitalisation: €250k. The latest transaction was reported on 25 August 2026 (Change in Substantial Holding). Among the most active insiders: Early Detection (NZ) Limited. The full history is accessible without an account.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 20,275 of 29,062 companies
38.5
score / 100
Value33
Quality44
FCF yld-58%
Earn yld4.6%
EV/EBITDA·
ROE3.8%
Gross mgn49%
Net mgn0.1%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 August 2026
Declarations5 total
ShareASXASX:2924-03126068-2A1692079
ShareASXASX:2924-03107151-2A1681941
ShareASXASX:2924-03088041-2A1671113
5 of 5 declarations
关于 GSS
GSS 是一家在健康和制药领域运营的公司。它在 XASX 市场上市。